Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda.
about
Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective studyEfavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapyAntiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz.Trends in prevalence of diarrhoea, Kaposi's sarcoma, bacterial pneumonia, malaria and geohelminths among HIV positive individuals in Uganda.First-line antiretroviral drug discontinuations in childrenCardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infectionThe changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa.Recent advances in HIV-associated cardiovascular diseases in Africa.Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation.Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets.Global impact of antiretroviral therapy-associated diarrhea.Peripheral neuropathy in children on stauvudine therapy.Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.Efavirenz is related to neuropsychiatric symptoms among adults, but not among adolescents living with human immunodeficiency virus in Kilimanjaro, Tanzania.
P2860
Q34445856-2D028872-8633-4152-A032-42DEF1E2A161Q34938889-594AE7A2-E6F3-4A77-BC48-EE4CBCBC6CD4Q35205900-ECEB8F41-C1BA-4C55-8A20-2906C761CFF6Q35547048-2535DD8B-F01B-4A61-B9A2-5DF428AB756CQ35737444-FC832F37-146C-46E9-A6EA-96A1B2D942E0Q36278763-0C55A23B-9E86-4E6E-AFDF-D1E07760CAF1Q36555275-7535AA34-6904-4CDC-B0BF-D1E836AE55ACQ36941665-ED9C1E9A-D563-466F-8C44-9EA0B00238B2Q37417023-3F1F3DAC-371B-4B92-9097-D8FBB0A18F29Q38107369-5D941BC7-8B8C-4FE2-B7E0-EFA0C18D7B24Q38660444-9EE6FF9F-9F15-4E33-AAB4-C6F6694DB63AQ38850249-07E1A1E0-638C-4F6F-A315-489608C5F961Q38851687-B8FB0ED4-C89B-4B9D-8771-F990C054A8B5Q43109126-5A39BA7C-66E8-4355-B24E-4E9ED27973A2Q43456653-24A96745-A34C-4AFB-8AD8-EE74ED226EBDQ45716506-95B79CC1-69FC-410F-A038-5442F6CE3A86Q47567926-B5FB3E70-92A0-44A2-BAB9-20479CC4A802
P2860
Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Safety and tolerability of ant ...... ren and adolescents in Uganda.
@en
type
label
Safety and tolerability of ant ...... ren and adolescents in Uganda.
@en
prefLabel
Safety and tolerability of ant ...... ren and adolescents in Uganda.
@en
P2093
P921
P1476
Safety and tolerability of ant ...... ren and adolescents in Uganda.
@en
P2093
Adeodata Kekitiinwa
Albert Maganda
Alice Asiimwe
Isaac Sebuliba
Israel Kalyesubula
Phillipa Musoke
Rita Atugonza
Vincent J Tukei
P304
P356
10.1097/QAI.0B013E3182423668
P407
P577
2012-03-01T00:00:00Z